Prespecified exploratory analysis of SELECT in 17,604 patients with CVD and overweight or obesity without diabetes: semaglutide vs placebo had fewer hospital admissions (18.3 vs 20.4 per 100 patient-years; MR 0.90) and fewer days in hospital (RR 0.89).
Secondary analysisn = 17,604
Nicholls et al. Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial